Letters

Kominos S.D. , Zaphyr K. Listeria infection therapy. Diagnost Med 1983; (May/June): 13–14.

Abramowicz M. , ed. Moxalactam disodium (Moxam). Med Lett Drugs Ther 1982; 24: 13.

Stamm A.M. Chloramphenicol: ineffective for treatment of listeria meningitis. Am J Med 1982; 72: 830.

Cherubin C. , Marr J. , Sierra M. , Becker S. Listeria and gram-negative bacillary meningitis in New York City, 1972–1979. Am J Med 1981; 71: 199–209.

Stamm A. , Dismukes W. , Simons B. Listeriosis in renal transplant recipients: report of an outbreak and review of 102 cases. Rev Infect Dis 1982; 4: 665–79.

Tuazon C.U. , Shamsuddin D. , Miller H. Antibiotic susceptibility and synergy of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chemother 1982; 21: 525–7.

Greene B.M. , Thomas F.E. , Alford R.H. Trimethoprim-sulfamethoxazole and brain abscess. Ann Intern Med 1975; 82: 812–3.

The United States Pharmacopeia. 20th ed. The National Formulary. 15th ed. Rockville, MD: The United States Pharmacopeial Convention, 1980: 958–9.

Muhammad N. , Bodner J.A. Separation and quantitation of chlortetracycline, 4-epitetracycline, 4-epianhydrotetracycline, and anhydrotetracycline in tetracycline by high-pressure liquid chromatography. J Pharm Sci 1980; 69: 928–30.

Stumpe K.O. , Kolloch R. , Higuchi M. , Kruck F. , Vetter H. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension, Lancet 1977; 2: 211–4.

Noth R.H. , McCallum R.W. , Contino C. , Havelick J.A. Tonic dopaminergic suppression of plasma aldosterone. J Clin Endocrinol Metab 1980; 51: 64–9.

Carey R.M. , Thorner M.O. , Ortt E.M. Effects of metoclopramide and bromocriptine on the renin-angiotensin aldosterone system in man, dopaminergic control of aldosterone. J Clin Invest 1979; 63: 727–35.

Sowers J.R. , Tuck M.L. , Golub M.S. , Sollars E.G. Dopaminergic modulation of aldosterone secretion is independent of alterations in renin secretion. Endocrinology 1980; 107: 937–41.

Edwards C.R.W. , Thorner M.O. , Miall O.A. , Al-Dujaili E.A.S. , Hanker J.P. , Besser G.M. Inhibition of the plasma aldosterone response to frusemide by bromocriptine. Lancet 1975; 2: 903–5.

Uberti E.C. , Fabbri B.L. , Margutti A.R. , Fersini S.M. , Pansini R. Effect of bromocriptine on the control of plasma aldosterone diurnal variation in normal supine man. Horm Res 1979; 10: 64–78.

Kourides R.N. , Weihl A.C. , Maloof F. The relationship between endogenous hyperprolactinaemia and plasma aldosterone. Clin Endocrinol 1979; 10: 187–93.

Pratt J.H. , Ganguly A. , Parkinson C.A. , Weinberger M.H. Stimulation of aldosterone secretion by metoclopramide in humans. Apparent independence of renal and pituitary mediation. Metabolism 1981; 30: 129–34.

McKenna T. , Island D.P. , Nicholson E. , Liddle G.M. Dopamine inhibits stimulated aldosterone biosynthesis in bovine adrenal cells. J Clin Invest 1979; 64: 287–91.

Nagahama S. , Fujimaki M. , Suzuki H. , Kavabe H. , Saito I. , Saruta T. In vivo and in vitro effect of metoclopramide on aldosterone secretion in rats. Acta Endocrinol 1983; 102: 589–93.

Norbiato G. , Bevilacqua M. , Raggi V. Effect of metoclopramide, a dopaminergic inhibitor on renin and aldosterone in idiopathic edema. Possible therapeutic approach with levodopa and carbidopa. J Clin Endocrinol Metab 1979; 48: 37–42.

Physicians' Desk Reference. New Jersey: Medical Economics Co., Inc., 1982: 945–6.

Post R.M. Carbamazepine's acute and prophylactic effects in manic and depressive illness: an update. Int Drug Ther Newslett 1982; 17: 5–10.

Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, D.C.: American Psychiatric Association, 1980: 208–9.

Okuma T. , Inanaga K. , Otsuki S. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study. Psychopharmacol 1979; 66: 211–7.

Ballenger J.C. , Post R.M. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Commun Psychopharmacol 1978; 2: 159–75.

Ballenger J.C. , Post R.M. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980; 137: 782–90.

Okuma T. , Inanaga K. , Otsuki S. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacol 1981; 73: 95–6.

Reid A.H. , Naylor G.J. , Kay D.S.G. A double-blind, placebo controlled crossover trial of carbamazepine in overactive severely mentally handicapped patients. Psychol Med 1981; 11: 109–13.

Folks D.G. , King L.D. , Dowdy S.B. Carbamazepine treatment of selected affectively disordered inpatients. Am J Psychiatry 1982; 139: 115–7.

Lipinski J.F. , Pope H.G. Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients. Am J Psychiatry 1982; 139: 948–9.

Melmon K.L. , Gilman A.G. , Mayer S.E. Principles of therapeutics. In: Gilman A.G. , Goodman L.S. , Gilman A. , eds. Goodman and Gilman's the pharmacologic basis of therapeutics, 6th ed. New York: Macmillan, 1980: 40–55.

Rall T.W. Central nervous system stimulants: the xanthines. In: Gilman A.G. , Goodman L.S. , Gilman A. , eds. Goodman and Gilman's the pharmacological basis of therapeutics, 6th ed. New York: Macmillan, 1980: 592–607.